EUVIMED · CrossrefJournal
Drug Metabolism and Pharmacokinetics
ISSN 1347-4367 · Elsevier BV
Latest articles
Assessment of infliximab biotransformation in patient serum by comparing mass-spectrometry and ligand-binding assay quantification
Translational limitations of a rat-derived hybrid pharmacokinetic–toxicodynamic model for chemotherapy-induced hematologic toxicity in humans
Microsomal and hepatocyte binding in drug discovery: Method suitability and lipophilicity-based predictions
UGT1A1 isoform-selective allosteric inhibition by dirithromycin
Impact of Membrane Permeability of P-glycoprotein Inhibitors on the Risk Assessment of Intestinal P-glycoprotein-Mediated Drug-Drug Interactions
Advances in In silico predictive models for DDI prediction: Implications and practical applications in drug discovery
Characterization of drug-drug interaction for antibody-drug conjugates and risk assessment using various approaches including physiologically based pharmacokinetic modeling
Applications of in vitro transporter assays for mechanistic characterization and prediction of clinical drug-drug interactions
Metabolism of simvastatin by Streptomyces griseolus CYP105A1 and its variants for the production of human simvastatin metabolites
Human aldo-keto reductase (AKR) 1C1 and 1C2 act as coactivators of pregnane X receptor, a master regulator of drug-metabolizing and gluconeogenesis enzymes
Drug-drug interaction between trastuzumab emtansine (T-DM1) and orally administered tacrolimus in a patient and in rats
Human brain organoids for understanding substance use disorders
Population pharmacokinetics of blonanserin in Japanese adolescent and adult patients with schizophrenia
Advancements in Microphysiological systems: Exploring organoids and organ-on-a-chip technologies in drug development -focus on pharmacokinetics related organs-
Sodium citrate buffer improves pazopanib solubility and absorption in gastric acid-suppressed rat model
Transcript abundance of hepatic drug-metabolizing enzymes in two dog breeds compared with 14 species including humans
Establishment of human intestinal organoids derived from commercially available cryopreserved intestinal epithelium and evaluation for pharmacokinetic study
Apple-derived extracellular vesicles modulate the expression of human intestinal bile acid transporter ASBT/SLC10A2 via downregulation of transcription factor RARα
High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database
Food effects on gastrointestinal physiology and drug absorption
Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality
Comparison of the inhibitory properties of the fruit component naringenin and its glycosides against OATP1A2 genetic variants
Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants
Adenovirus vector-based vaccine for infectious diseases
Inhibitory effects of indoxyl sulfate and creatinine on the renal transport of meropenem and biapenem in rats
Physiologically based pharmacokinetic modeling of altered tizanidine systemic exposure by CYP1A2 modulation: Impact of drug-drug interactions and cigarette consumption
Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24
Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers
Assessing cytochrome P450-based drug-drug interactions with hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats
WDR23 regulates the expression of Nrf2-driven drug-metabolizing enzymes
EUVIMED